Categories AlphaGraphs, Earnings, Health Care
Infographic: Key highlights from Biogen (BIIB) Q2 2022 earnings results
Biogen Inc. (NASDAQ: BIIB) reported second quarter 2022 earnings results today.
Total revenue decreased 7% year-over-year to $2.58 billion.
Net income attributable to Biogen Inc. was $1 billion, or $7.24 per share, compared to $448.5 million, or $2.99 per share, last year. Adjusted EPS was $5.25.
Biogen raised its revenue and adjusted EPS guidance for the full year of 2022 based on better-than-expected topline performance and continued cost management. For FY2022, revenue is now expected to be $9.9-10.1 billion and adjusted EPS is now expected to be $15.25-16.75 compared to the previous ranges of $9.7-10 billion for revenue and $14.25-16.00 for adjusted EPS.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
Target (TGT): A look at some of the challenges faced by the retailer in 3Q24
Shares of Target Corporation (NYSE: TGT) stayed green on Thursday, recovering from the stumble it took a day ago after delivering disappointing results for the third quarter of 2024 and
